Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07633119 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase Ⅲ Clinical Study of SNA02-48 Injection

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The primary objective of this clinical trial is to compare the efficacy and safety of SNA02-48 injection with Human Tetanus Immunoglobulin (HTIG) for tetanus prophylaxis.
Trial Details
NCT Number NCT07633119
Lead Sponsor Sinovac Life Sciences Co., Ltd.
Conditions
(from sponsor)		 Tetanus
Related terms Tetanus
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov